EVIDENCE (Evaluations to Inform Decisions using Economics and Epidemiology) is a 5-year HIV/AIDS Economic Research activity funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through a Co-operative Agreement between the United States Agency for International Development (USAID) South Africa and the Health Economics and Epidemiology Research Office (HE2RO). The overall purpose of EVIDENCE is to conduct health economics and epidemiology research to guide evidence-based policy change in support of the goals of the South African National Strategic Plan for HIV, TB and STI’s 2017-2022 (NSP) and the PEPFAR Country Operational Plans 2018-2022.
The EVIDENCE framework identifies four technical focus areas for cost and budget modeling, effectiveness and cost analysis in HIV and TB care and treatment service delivery programs and innovative models for prioritizing healthcare resources.
In each focus area, a set of integrated activities is proposed, aimed at providing policy-relevant information on the key questions facing policy makers in that area. Methodological approaches to be used for this work include cost, outcome, and cost-effectiveness analysis; impact, cost, and budget modeling; program evaluation to inform planning and targeting of resources; leveraging of existing data sources; and focus on priority districts and key and vulnerable populations. Results generated by EVIDENCE will provide information to help guide decisions about program efficiency, guideline changes, models of service delivery, budgeting and resource allocation, and quality.
EVIDENCE builds on substantial knowledge, skills, relationships, and accomplishments over 15 years by the HE2RO team and partners under the INROADS Innovation Activity, prior cooperative agreements with USAID, and projects supported by other funders. Sub-awards on the EVIDENCE program include the Department of Global Health, Boston University (a long-standing collaboration since 2004) and the Centre for Economic Governance and Accountability in Africa (CEGAA).
HE2RO staff involved
Receive newsletters and keep up to date with developments at HE2RO.